BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Digital Twin Studies: the Next Inflection in Equal, Equitable, Healthcare

  The Media and Innovation Lab at the University of Miami is developing digital twins of patients in an effort to bring robust healthcare to underserved communities.

  March 16, 2022

   · 

  4 min read

   · 

  Gail Dutton
• 

  Business

  Money on the Move: March 9-15

  The companies that got money this week were the ones investing in ambitious, future-looking technologies, such as RNA genomics, biochips and antibody-drug conjugates.

  March 16, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Policy

  COVID-19 Isn’t Done with Us Yet, Vaccine Patents and a 4th Booster

  Now that Omicron is becoming less common, its sister variant, BA.2, seems to be surging worldwide and in the U.S. For that and more, continue reading.

  March 16, 2022

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  New Data from Biogen Supports Aduhelm’s Clinical Effectiveness

  Biogen reported new data from a long-term extension phase of the Phase III clinical studies of Aduhelm (aducanumab) for Alzheimer’s disease.

  March 16, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Shoreline Poaches Pfizer Cancer Vaccine Head, Robert Hollingsworth

  Robert Hollingsworth, PhD, a former Pfizer executive who oversaw the development of cancer vaccines and immunotherapeutics, has taken on the role of the CSO at Shoreline Biosciences.

  March 16, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Frazier Life Sciences Commits $1B to Nurturing New Biotech Companies

  In total, FSI XI has netted over $987 million in commitments to drive the success of Frazier’s ongoing investment strategy.

  March 16, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano
• 

  Business

  Sanofi and Seagen: a Match Made in ADC Heaven

  Healthcare giant Sanofi and cancer-focused biotech company Seagen Inc. announced an exclusive collaboration agreement to develop antibody-drug conjugates (ADCs) for cancer treatments.

  March 16, 2022

   · 

  2 min read

   · 

  Hannah Chudleigh
• 

  Policy

  Novartis, Lilly, Merck and More Halt Business Operations in Russia

  More pharmaceutical companies are joining to put economic pressure on Russia by suspending some or all operations within that country following the invasion of Ukraine.

  March 16, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Four Cancer Clinical Trials Advance with Blessing of FDA

  Several biopharma companies celebrate the U.S. Food and Drug Administration’s approval for clinical trials involving therapeutics for cancer treatment.

  March 16, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Business

  Biogen Returns Rights for Dry AMD Drug to Troubled Catalyst

  Biogen returned the rights to a dry age-related macular degeneration (dAMD) drug to Catalyst Biosciences. Biogen also ended the partnership regarding other dry AMD.

  March 16, 2022

   · 

  3 min read

   · 

  Alex Keown